Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 2, 1998, Pages 109-112

  Bostic, G D ^a   Perri, M B ^a   Thal, L A ^a   Zervos, M J ^a,b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; EPEREZOLID; GENTAMICIN; LINEZOLID; OXAZOLIDINONE DERIVATIVE; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOMYCIN;

EID: 0031913313     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00210-1     Document Type: Article

References (19)

1. Bonilla HF, Perri MB, Kauffman CA, Zervos MJ. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium. Diagn Microbiol Infect Dis. 25:1996;127-131.
2. Brumfitt W, Hamilton-Miller JMT, Shah S. In vitro activity of RP59500, a new semisynthetic streptogramin antibiotic against gram-positive bacteria. J Antimicrob Chemother. 30:(suppl):1992;A29-A37.
3. Daly JS, Eliopoulos GM, Reizner E, Moellering RC Jr. Activity and mechanisms of action of DuP 105 and DuP 721, new oxazolidinone compounds. J Antimicrob Chemother. 21:1988;721-730.
4. Daly JS, Eliopoulis GM, Willey S, Moellering RC Jr. Mechanism for action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob Agents Chemother. 32:1988;1341-1346.
5. Eliopolous GM, Wennersten CB, Gold HS, Moellering RC Jr. In vitro activities of new oxazolidinone antimicrobial agents against enterococci. Antimicrob Agents Chemother. 40:1996;1745-1747.
6. Facklam RR, Collins MD. Identification of enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 27:1989;735-737.
7. French P, Venuti E, Fraimow HS. In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium. Antimicrob Agents Chemother. 37:1993;2736-2739.
8. Jones RN, Barrett MS, Erwin ME. In vitro activity and spectrum of LY333328, a novel glycopeptide derivative. Antimicrob Agents Chemother. 41:1996;488-493.
9. Kaatz GW, Seo SM. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 40:1996;799-801.
10. Knapp C, Moody JA (1992) Tests to assess bactericidal activity. In: Clinical Microbiology Procedures Handbook. Ed, Isenberg HC. Washington DC: American Society for Microbiology, 5.16.1-5.16.32.
11. Moellering RC, Wennersten C, Weinberg AN. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J Lab Clin Med. 77:1971;821-828.
12. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev. 3:1990;46-65.
13. National Committee for Clinical Laboratory Standards (1994) Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards.
14. Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RDG. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrob Agents Chemother. 20:1996;213-221.
15. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin resistant enterococcal infections. Clin Infect Dis. 20:1995;1137-1144.
16. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med. 91:(suppl 3B):1991;72S-75S.
17. Weiss WJ, Jacobus NV, Petersen PJ, Testa RT. Susceptibility of enterococci, methicillin resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines. J Antimicrob Chemother. 36:1995;225-230.
18. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikessel TS, Schaberg DS. Nosocomial infection by gentamicin resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med. 106:1987;687-691.
19. Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ. In vitro activities of U100592 and U100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother. 40:1996;839-845.